https://www.selleckchem.com/pr....oducts/n-nitroso-n-m
i. 68·4 to 72·1) per cent after 1 year, and 74·3 (72·5 to 76· per cent after 3 years. Neoadjuvant treatment (hazard ratio (HR) 0·75, 95 per cent c.i. 0·66 to 0·85), blood loss greater than 300 ml (HR 0·86, 0·76 to 0·97), anastomotic leak (HR 0·41, 0·33 to 0·5, T3 category (HR 0·63, 0·47 to 0·83), T4 category (HR 0·62, 0·42 to 0·9 and UICC stage IV (HR 0·57, 0·41 to 0·8 were possible predictors of delayed stoma reversal. In one-quarter of the patients the diverting stoma had not been reversed 3 years after the inte
Like
Comment
Share
